Amy D Burans, | |
4570 Roundhill Rd, Ellicott City, MD 21043-6751 | |
(410) 313-2825 | |
Not Available |
Full Name | Amy D Burans |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 4570 Roundhill Rd, Ellicott City, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164994836 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 01167 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Amy D Burans, 3733 Falling Green Way, Mount Airy, MD 21771-8009 Ph: (410) 925-8887 | Amy D Burans, 4570 Roundhill Rd, Ellicott City, MD 21043-6751 Ph: (410) 313-2825 |
News Archive
A study from the Family Acceptance Project has found that lesbian, gay, bisexual, and transgender young people who experience sexual orientation change efforts during adolescence report attempts to change their sexual orientation both by their parents and by therapists and religious leaders.
Ben Franklin was right, at least on the healthy part. "Early to bed and early to rise" appears to have helped a cross-section of early-bird Australian youths keep slimmer and more physically active than their night-owl peers, even though both groups got the same amount of sleep.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that its Phenoptics™ quantitative pathology research system was an important component in skin cancer research published online in the April 19 edition of the New England Journal of Medicine.
Small cell lung cancer (SCLC) patients treated with high-dose chemotherapy did not have better survival rates than those treated with standard doses, according to a randomized controlled trial published online April 8 in the Journal of the National Cancer Institute .
apceth, a global leader in engineered cell therapies, today announced the successful completion of the Phase I and initiation of the Phase II part of its ongoing monocentric Phase I/II clinical trial TREAT-ME 1 with the engineered cell therapeutic product Agenmestencel-T, at the Klinikum Grosshadern in Munich.
› Verified 8 days ago
Maria Hindman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10910 Clarksville Pike, Ellicott City, MD 21042 Phone: 410-313-6600 | |
Mrs. Rachel Beth Paulin Stein, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10910 Clarksville Pike, Ellicott City, MD 21042 Phone: 410-313-6600 | |
Ms. Nausheen Mushtaq, MS SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10910 Clarksville Pike, Ellicott City, MD 21042 Phone: 410-313-6600 | |
Stacy Peretti, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10910 Clarksville Pike, Ellicott City, MD 21042 Phone: 410-313-6600 | |
Kelsey Rooney, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10910 Clarksville Pike, Ellicott City, MD 21042 Phone: 410-313-2806 | |
Karolyn Crutchfield, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10910 Clarksville Pike, Ellicott City, MD 21042 Phone: 410-313-2819 | |
Communication Joy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13094 Williamfield Dr, Ellicott City, MD 21042 Phone: 301-300-9545 |